🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

High interest rates strain small and midsize US stocks

EditorMalvika Gurung
Published 27/09/2023, 08:32
© Pavlo Gonchar / SOPA Images/Sipa via Reuters Connect
US500
-
US2000
-

The Federal Reserve's decision to maintain higher borrowing costs for an extended period is causing a strain on small and midsize US stocks, with the Russell 2000 small-cap index experiencing an 11% decline since its peak in July. The S&P 500 has also seen a 7% decrease over the same period, reflecting the acute impact of rate increases on smaller stocks.

According to analysts, a key factor contributing to the decline in small-cap stocks is the rapid rise in interest costs for smaller companies. Interest expenses for the S&P 600, another small-cap index, reached a record high in the second quarter of this year, marking uncharted territory for small caps. These companies now face the prospect of either persisting high rates or a potential economic recession.

Smaller companies generally have weaker balance sheets than large-cap firms. Debt as a multiple of profits is higher and interest payments consume a larger share of earnings. Particularly for Russell 2000 companies, 30% of their debt stock is floating-rate, which exposes them to a rising rate environment. This is significantly higher than the 6% figure for the S&P 500.

"Rising rates will pinch and defaults are likely to rise," warned Dec Mullarkey, managing director at investment firm SLC Management. He added that smaller companies tend to rely more on bank lending, which has become increasingly restrictive. These firms also face more competition and have less pricing power, which puts pressure on margins as inflation remains high and wages increase.

Compared to large-cap indices like the S&P 500, small-cap indices contain more regional banks and industrials. These sectors typically suffer when investors lower their expectations for economic growth. The Russell 2000 also includes a larger proportion of life sciences firms, many of which are unprofitable, increasing their sensitivity to changes in growth and interest rates.

While larger companies have also felt the impact of higher funding costs, the increase has been more subdued. This is partly due to their lower cost of capital and efforts to extend debt maturities in response to the pandemic. Large-cap firms have also benefited from larger cash reserves, which now generate more interest income thanks to higher rates. Tech companies, in particular, have seen a significant rise in interest income.

Despite current challenges, lower small-cap valuations could potentially attract buyers in the future. Ryan Hammond of Goldman Sachs's US equity strategy team noted that economic growth and starting valuations are crucial factors for Russell 2000 returns. If the economy is heading for a soft landing, as Goldman expects, small caps may still perform well.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.